A Phase 2 clinical trial published in the New England Journal of Medicine (2023) demonstrated participants receiving retatrutide achieved up to 24.2% mean weight reduction over 48 weeks the highest reduction reported for any investigational compound in its class at that time
Together, they reduce hunger and improve energy regulation
It triggers a strong, clean pulse of GH without significantly affecting other hormones, particularly cortisol (the stress hormone) and prolactin
Current guidelines recommend against tirzepatide while nursing, as the medication has not been studied in lactating women and could theoretically affect milk production or composition
Lincoln's GLP-1 market benefits from two competing health systems, Bryan Health and CHI St
Monthly list prices have exceeded $1,000 per patient, with injectable semaglutide (Wegovy/Ozempic) priced at $1,3001,400 per month at retail ( [1] )